We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > depression drug

News List

Takeda receives Ministry approval for depression drug biospectrumasia
September 23, 2019
Vortioxetine is already approved in 83 countries, including US, Europe, Canada, Chile, China, Mexico, Argentina, South Korea, Turkey, Australia, Hong Kong, S.A.R., China, Singapore and South Africa.
Sage strategy for postpartum depression drug Zulresso keys on patient support fiercepharma
July 04, 2019
Postpartum depression is complex—and so is the first FDA-approved treatment. The 60-hour inpatient infusion process for Sage Therapeutics' Zulresso calls for more than the typical information and education.
Sage wins OK for depression drug Zulresso fiercepharma
March 20, 2019
Up next? Major marketing challenges
Will third trial be the charm for Alkermes' depression drug? fiercebiotech
August 22, 2017
Alkermes hopes the drug could help millions of people with resistant depression.